Aethlon Medical Statistics
Share Statistics
Aethlon Medical has 16.09M
shares outstanding. The number of shares has increased by 48.62%
in one year.
| Shares Outstanding | 16.09M |
| Shares Change (YoY) | 48.62% |
| Shares Change (QoQ) | 47.95% |
| Owned by Institutions (%) | 3.16% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 4,415 |
| FTD / Avg. Volume | 2.98% |
Short Selling Information
The latest short interest is 102.08K, so 0.63% of the outstanding
shares have been sold short.
| Short Interest | 102.08K |
| Short % of Shares Out | 0.63% |
| Short % of Float | 0.64% |
| Short Ratio (days to cover) | 1.08 |
Valuation Ratios
The PE ratio is -0.36 and the forward
PE ratio is -0.71.
Aethlon Medical's PEG ratio is
0.02.
| PE Ratio | -0.36 |
| Forward PE | -0.71 |
| PS Ratio | 0 |
| Forward PS | 0 |
| PB Ratio | 0.75 |
| P/FCF Ratio | -0.42 |
| PEG Ratio | 0.02 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Aethlon Medical.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.4,
with a Debt / Equity ratio of 0.16.
| Current Ratio | 3.4 |
| Quick Ratio | 3.4 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | -0.08 |
| Debt / FCF | -0.09 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-872,012.43 |
| Employee Count | 14 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 3 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -9.52% in the
last 52 weeks. The beta is 1.94, so Aethlon Medical's
price volatility has been higher than the market average.
| Beta | 1.94 |
| 52-Week Price Change | -9.52% |
| 50-Day Moving Average | 0.38 |
| 200-Day Moving Average | 0.46 |
| Relative Strength Index (RSI) | 51.46 |
| Average Volume (20 Days) | 148,079 |
Income Statement
| Revenue | n/a |
| Gross Profit | -359.06K |
| Operating Income | -12.64M |
| Net Income | -12.21M |
| EBITDA | -11.85M |
| EBIT | -12.21M |
| Earnings Per Share (EPS) | -4.86 |
Full Income StatementBalance Sheet
The company has 5.44M in cash and 940.32K in
debt, giving a net cash position of 4.5M.
| Cash & Cash Equivalents | 5.44M |
| Total Debt | 940.32K |
| Net Cash | 4.5M |
| Retained Earnings | -154.57M |
| Total Assets | 6.53M |
| Working Capital | 3.14M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -10.13M
and capital expenditures -250.87K, giving a free cash flow of -10.38M.
| Operating Cash Flow | -10.13M |
| Capital Expenditures | -250.87K |
| Free Cash Flow | -10.38M |
| FCF Per Share | -4.13 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
